−400 KRW
−8.76 B KRW
3.42 B KRW
17.37 M
About GENOMICTREE INC.
Sector
Industry
CEO
Sung-Whan An
Website
Headquarters
Daejeon
Founded
2000
ISIN
KR7228760005
FIGI
BBG00DBKVJY1
Genomictree, Inc. engages in the development and supply of diagnostic products for cancer screening and prognosis. Its products include equipment for detection of cancer, diagnostics, and other infectious diseases. The company was founded by Sung-Whan An and Chi-Wang Yoon on October 6, 2000 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 228760 is 21,150 KRW — it has increased by 5.06% in the past 24 hours. Watch GENOMICTREE INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOMICTREE INC. stocks are traded under the ticker 228760.
228760 stock has risen by 0.46% compared to the previous week, the month change is a 53.63% rise, over the last year GENOMICTREE INC. has showed a 4.19% increase.
228760 reached its all-time high on May 13, 2019 with the price of 39,700 KRW, and its all-time low was 8,300 KRW and was reached on Oct 21, 2022. View more price dynamics on 228760 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
228760 stock is 8.29% volatile and has beta coefficient of 0.66. Track GENOMICTREE INC. stock price on the chart and check out the list of the most volatile stocks — is GENOMICTREE INC. there?
Today GENOMICTREE INC. has the market capitalization of 497.79 B, it has decreased by −9.19% over the last week.
Yes, you can track GENOMICTREE INC. financials in yearly and quarterly reports right on TradingView.
228760 net income for the last quarter is −3.06 B KRW, while the quarter before that showed −2.81 B KRW of net income which accounts for −8.66% change. Track more GENOMICTREE INC. financial stats to get the full picture.
No, 228760 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 79.00 employees. See our rating of the largest employees — is GENOMICTREE INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMICTREE INC. EBITDA is −13.53 B KRW, and current EBITDA margin is −473.56%. See more stats in GENOMICTREE INC. financial statements.
Like other stocks, 228760 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMICTREE INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMICTREE INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMICTREE INC. stock shows the buy signal. See more of GENOMICTREE INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.